Can Faecal Immunochemical Testing (FIT) Improve the Pathway for Patients with Lower GI Cancers?

At the ACB Focus meeting in April 2016, Alpha Laboratories organised a panel of experts to discuss the ramifications of the new NICE NG12 Guideline – Suspected cancer: recognition and referral, in relation to bowel cancer. Watch the seminars presented by: Professor Callum Fraser, Senior Research Fellow, School of Medicine, University of Dundee; Dr Ian Godber, Consultant Clinical Scientist, NHS Lanarkshire and Mr Paul Skaife, Consultant Colorectal Surgeon, Aintree University Hospitals NHS Foundation Trust. In addition there is a link to the interactive audience Q&A session that followed.